Thc Biomed Intl Stock Price, News & Analysis
Company Description
Thc Biomed Intl (OTC Link: THCBF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.4M.
THCBF stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of THCBF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Thc Biomed Intl (THCBF) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $2.4M, THCBF is classified as a micro-cap stock with approximately 163.9M shares outstanding.
Latest News
Thc Biomed Intl has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings. View all THCBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
THCBF Company Profile & Sector Positioning
Thc Biomed Intl (THCBF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing THCBF often look at related companies in the same sector, including Medical Mari (MJNA), Tilt Hldgs Inc (TLLTF), Indo Global Exchanges Pte Ltd (IGEX), Nxgen Brands (NXGB), and Blueberries Medi (BBRRF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate THCBF's relative position within its industry.